After the biotech's shares fell almost 20% Tuesday following its announcement that it would be raising capital two different ways, Ardelyx (NASDAQ: ARDX) stock was trading 14.3% lower early Wednesday afternoon after it revealed the pricing for its secondary stock offering.Ardelyx will sell 12.5 million shares at $4 per share to raise $50 million in the secondary offering.